Furthermore we believe that it is highly probable that Solv-Ex's November 15,1996 Reg S offering may also be the subject of an investigation. We believe that there is no reason to suspect any investor who ells Solv-Ex stock short of any wrong doing. On the contrary, we see no justification for buying Solv-Ex stock. Solv-Ex has been accused in at least four separate courts of disseminating false information, deceit, fraud, concealing material adverse facts, and artificially inflating its stock price. Short selling involves a risk not associated with the purchase of stock including, but not only limited to, unlimited loss and stock borrowing risks.
Additional information is available upon request.